CGPCS
HZNP

Capital Group Private Client Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Capital Group Private Client Services’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-131,094
Closed -$14.3M – 248
2023
Q1 		$14.3M Sell
131,094
-2,046
-2% -$226K 0.18% 115
2022
Q4 		$15.2M Buy
133,140
+24,065
+22% +$2M 0.19% 118
2022
Q3 		$6.75M Sell
109,075
-1,263
-1% -$88.3K 0.09% 144
2022
Q2 		$8.8M Sell
110,338
-789
-0.7% -$74.7K 0.11% 144
2022
Q1 		$11.7M Buy
+111,127
New +$10.8M 0.13% 129

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return